Is Subject #12312982 the Key to Proving Pfizer Vaccine Trial Fraud?

The Story of Augusto Roux

Josh Guetzkow

Subject # 12312982 in Pfizer study C4591001 is Augusto Roux, a 35-year old lawyer from Buenos Aires, Argentina who volunteered for Pfizer’s stage 3 trial of its COVID-19 vaccine (or whatever you want to call it) in order to protect his mother with emphysema.

His story and some of the shenanigans surrounding the Argentinian trial site have been amply covered by Dr. David Healy in three sprawling but extremely important blog posts: 1, 2, 3. The first one was published March 1st, but it was only last week that I caught on to this story, so I’m assuming most of you probably aren’t familiar with it. So please share this — we’ve got to get the word out, because Augusto Roux may very well hold the key to bringing down the Pfizer vaccine trial, or a least proving fraud at the largest trial site that was home to over 10% of the participants in the trial.

If you don’t have time to sink your teeth into David’s posts (even just the 1st one), I’ll bring you up to speed on key details:

On the way home after his second dose on Sept. 9, 2020, he began feeling unwell, developed a high fever and felt terribly ill until he fainted on Sept. 11 and finally went to the hospital on Sept. 12 (not the one where the trial was being run). They did a thorough work-up, including a CAT scan of his chest that showed an abnormal collection of fluid around the outside of the heart. Basically he had pericarditis.

On Sept. 14, he was discharged. The doctor wrote in his chart that he had suffered an adverse reaction to the vaccine. Augusto was told by hospital staff they there had been a huge influx of people from the clinical trial coming to the hospital (there were 2,981 subjects enrolled in the trial before Augusto), so his experience was not new to them. (The trial site managed to enlist several thousand subjects in just a few weeks.) One nurse estimated they had seen around 300 people.

Now here’s where it gets really interesting, and we know all of this because Augusto, a lawyer, successfully sued to get his medical and trial clinical records, even though it took him over a year. I will try to make a long story short:

Even though Augusto had a negative PCR test at the hospital, and even though the doctor at the hospital wrote that his condition was due to the vaccine, when Augusto called the trial site on Sept. 14 to notify them he was in the hospital, they wrote down in his clinical trial record that he had been admitted for a bilateral pneumonia that had nothing to do with the “investigational product” — even though that was not what he told them.

On October 7, the clinical trial notes that “at the request of the sponsor” (AKA Pfizer), the adverse event code was update to COVID-19 disease. And that’s how Pfizer made cases of myocarditis and pericarditis disappear, by sweeping them under the rug of COVID-19. Moreover, the diagnosis of COVID-19 would not count against the efficacy calculations, since those required a positive PCR test to confirm diagnosis.

Two days later On Oct. 9, Augusto was formally unblinded. The principal investigator for the trial, Fernando Polack (pictured below), had told him that Augusto could only be unblinded if his life were in danger, which is simply untrue. So Augusto appealed to ANMAT, the Argentinian FDA. In a formal hearing they forced the trial investigators to tell Augusto if he had received the vaccine or not. He had. If you think the timing of the Oct. 7 request by Pfizer to change his AE is suspect, you’re not alone.